The incidence of GI bleeding is greater in males than in females, in all age groups; however, the death rate is similar in both sexes. Worldwide, acute lower GI bleeding accounts for 1-2% of hospital emergencies, with 15% of these presenting as massive bleeding and about 5% requiring operative intervention.
Gastrointestinal (GI) bleeding is any type of bleeding that starts in the GI tract that composed from esophagus, stomach, small intestine, large intestine, rectum, and anus. GI bleeding is a symptom of a disease or condition, rather than a disease or condition itself.
Peptic ulcer, esophageal varices and hemorrhoids are major causes for GI bleeding. Other causes include cancers, inflammatory bowel diseases and angiodysplasia. The symptoms of that depend on the location and the severity of bleeding. Vomiting blood or a dark stool are two common of them.
Several diagnostic procedures are available to confirm the condition. Endoscopy can be used to investigate and treat most cases. It is considered very important to treat GI bleeding and its underlying cause as soon as possible, as it could lead to serious health complications if left untreated.
Gastrointestinal bleeding (also called “GI” bleeding) refers to a leak of blood from any part of the gastrointestinal tract. It is divided into 2 types based on its original location:
Several conditions increasing the risk of having major causes of GI bleeding, these include:
Mild cases of GI bleeding may be asymptomatic. In more advanced cases some symptoms may be noticed, like:
It is may be enough to base on symptoms and physical examination to diagnose some cases like bleeding from hemorrhoids and anal fissures, while more complicated ones need more tests and diagnostic procedures, as:
Dealing with GI bleeding depends on its cause and severity. Asymptomatic gastrointestinal bleeding detected on routine tests may only require supportive care, like iron-supplementation therapy while keep looking for the cause in order to treat it and avoid progression or possible complications.
However, in severe and active cases, treatment begins with blood transfusions and intravenous fluids as needed and ordered by doctor. These situation needs urgent intervention by endoscopy and its therapies that include: epinephrine injection, thermocoagulation (treat the bleeding site and surrounding tissue with a heat probe), application of clips, and banding.
In cases of peptic ulcers as etiology for GI bleeding - that often caused by H. pylori - is treated using the triple therapy, which consists of two different antibiotics and an acid-suppressing drug, mainly a proton pump inhibitor. These drugs are given for specific period, then a test for confirmation done at least four weeks after the treatment. If it showed the treatment was unsuccessful, another round of treatment is needed with a different combination of antibiotics.
Colon polyps, tumor or affected areas of inflammatory bowel disease may require surgical resection of disease fragments or diseased parts. Hemorrhoids and anal fissures may respond to topical and habitual treatments such as ointments, sitz bath and controlling constipation. However, sometimes they may require surgical intervention or even endoscopic coagulation or clipping.
GI bleeding runs inside the body, so it can go unnoticed for a long period, or it could be severe enough to cause life-threatening consequences even in short period. Prolonged or massive bleeding can cause certain complications. These include:
Some cases are associated with an increased mortality, recurrent bleeding, the need for endoscopic hemostasis, or surgery. Risk factors for GI bleeding complications include:
Detecting and treating the conditions that cause the bleeding GI bleeding is the cornerstone for avoidance of that health problem. Some ways that reduce the risk are:
This condition is associated with significant morbidity and mortality. Patients of advanced age and patients with comorbid conditions are at the greatest risk. One or more comorbid illnesses have been noted in 98.3% of mortalities in upper GI bleeding and considered as the primary cause of death for 72.3% of them. Identification of the bleeding point is the most important initial step in treatment; once the bleeding point is localized, the treatment options are straightforward and curative. The chance of recurrence is diminished if the underlying disease has been fixed.
The incidence of GI bleeding is greater in males than in females, in all age groups; however, the death rate is similar in both sexes. Worldwide, acute lower GI bleeding accounts for 1-2% of hospital emergencies, with 15% of these presenting as massive bleeding and about 5% requiring operative intervention.